Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhaled nitric oxide.

William E Hurford1

  • 1Department of Anesthesia and Critical Care, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. whurford@partners.org

Respiratory Care Clinics of North America
|December 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasound-Guided Continuous Bilateral Erector Spinae Plane Blocks Are Associated with Reduced Opioid Consumption and Length of Stay for Open Cardiac Surgery: A Retrospective Cohort Study.

Journal of clinical medicine·2021
Same author

Sugammadex versus neostigmine for routine reversal of rocuronium block in adult patients: A cost analysis.

Journal of clinical anesthesia·2020
Same author

Data and meta-analysis for choosing sugammadex or neostigmine for routine reversal of rocuronium block in adult patients.

Data in brief·2020
Same author

Neuromuscular Blockade Applicability in Early Acute Respiratory Distress Syndrome.

Anesthesiology·2020
Same author

In Response.

Anesthesia and analgesia·2018
Same author

Role of the anesthesiologist-intensivist outside the ICU: opportunity to add value for the hospital or an unnecessary distraction?

Current opinion in anaesthesiology·2018

Inhaled nitric oxide (NO) shows promise for treating pulmonary hypertension and hypoxemia. It may reduce the need for extracorporeal membrane oxygenation (ECMO) in infants with respiratory failure, but more clinical trials are needed.

Area of Science:

  • Medical Science
  • Respiratory Medicine
  • Pediatric Critical Care

Background:

  • Pulmonary hypertensive diseases and hypoxemia are serious conditions requiring effective treatments.
  • Inhaled nitric oxide (NO) is a potential therapeutic agent for these conditions.
  • Extracorporeal membrane oxygenation (ECMO) is a life-support measure for severe respiratory failure in neonates and infants.

Purpose of the Study:

  • To explore the therapeutic potential of inhaled NO for pulmonary hypertension and hypoxemia.
  • To evaluate the role of inhaled NO in reducing the need for ECMO in infants with acute hypoxemic respiratory failure.
  • To highlight the need for clear guidelines regarding NO therapy, including indications, contraindications, dosing, and toxicity.

Main Methods:

  • Review of existing literature and clinical data on inhaled NO therapy.

Related Experiment Videos

  • Analysis of the impact of iNO on ECMO utilization in neonatal and infant populations.
  • Identification of knowledge gaps and areas requiring further investigation.

    • Main Results:

    • Inhaled NO presents a novel therapeutic approach for pulmonary hypertension and symptomatic relief of hypoxemia.
    • The use of iNO may decrease the reliance on ECMO for newborns and infants experiencing acute hypoxemic respiratory failure.
    • Comprehensive understanding of NO's therapeutic and toxic effects is crucial for safe and effective application.

    Conclusions:

    • Inhaled NO offers a promising alternative or adjunctive therapy for specific respiratory conditions.
    • Further randomized clinical trials are essential to establish definitive efficacy and safety profiles.
    • Clear delineation of indications, contraindications, dosing, and toxicity is necessary before widespread clinical adoption.